e-learning
resources
Munich 2006
Wednesday 06.09.2006
Epidemiological and clinical aspects of tuberculosis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Response to empirical anti-tuberculosis treatment in patients with sputum smear-negative pulmonary tuberculosis
S. Bilgin, M. Yalcinsoy, A. Baran, O. Sogukpinar, S. Gungor, B. B. Afsar, E. Akkaya (Istanbul, Turkey)
Source:
Annual Congress 2006 - Epidemiological and clinical aspects of tuberculosis
Session:
Epidemiological and clinical aspects of tuberculosis
Session type:
Electronic Poster Discussion
Number:
4876
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Bilgin, M. Yalcinsoy, A. Baran, O. Sogukpinar, S. Gungor, B. B. Afsar, E. Akkaya (Istanbul, Turkey). Response to empirical anti-tuberculosis treatment in patients with sputum smear-negative pulmonary tuberculosis. Eur Respir J 2006; 28: Suppl. 50, 4876
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Related content which might interest you:
Delays in diagnosis and treatment of patients with smear-positive pulmonary tuberculosis
Source: Eur Respir J 2005; 26: Suppl. 49, 689s
Year: 2005
A review of the diagnosis and treatment of smear-negative pulmonary tuberculosis
Source: Annual Congress 2008 - Problems in managing pulmonary and extrapulmonary tuberculosis
Year: 2008
Time course of sputum positivity during chemotherapy in smear-positive pumonary tuberculosis
Source: Eur Respir J 2001; 18: Suppl. 33, 339s
Year: 2001
Characteristics of smear-positive pulmonary tuberculosis patients with delayed diagnosis
Source: Virtual Congress 2020 – Non-tuberculous mycobacteria and latent tuberculosis infection
Year: 2020
Performance of RD-1 based blood assays in clinical management of smear-negative pulmonary and extra-pulmonary tuberculosis
Source: Annual Congress 2007 - Gamma-interferon-based tests to diagnose tuberculosis infection and disease
Year: 2007
Efficiency of standard chemotherapy of patients with pulmonary TB with relapses and treatment failure at drug resistance of M. tuberculosis
Source: Eur Respir J 2001; 18: Suppl. 33, 339s
Year: 2001
The rational chemotherapy of new smear-positive lung tuberculosis with extended cavitary disease
Source: Eur Respir J 2006; 28: Suppl. 50, 9s
Year: 2006
Effectiveness of intravenous isoniazid and ethambutol administration in patients with new smear positive drug-susceptible pulmonary tuberculosis with tuberculous meningoencephalitis and HIV co-infection in the intensive phase of treatment
Source: International Congress 2019 – Tuberculosis: treatment and management
Year: 2019
Treatment results of new cases of sputum-positive pulmonary tuberculosis with standard chemotherapeutical regimen
Source: Eur Respir J 2002; 20: Suppl. 38, 367s
Year: 2002
Therapy of the patients with culture-positive pulmonary tuberculosis: doctors compliance
Source: Eur Respir J 2006; 28: Suppl. 50, 304s
Year: 2006
Cough improves earlier than sputum after treatment initiation in hospitalised patients with pulmonary tuberculosis
Source: Virtual Congress 2020 – Tuberculosis and adverse events in different populations
Year: 2020
Sputum induction to aid diagnosis of smear-negative or sputum-scarce tuberculosis in adults in HIV-endemic settings
Source: Eur Respir J 2014; 43: 185-194
Year: 2004
Factors influencing sputum conversion among smear-positive pulmonary tuberculosis patients in Morocco
Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management III
Year: 2013
Monitoring of drug resistance of TB mycobacteria in new pulmonary TB patients
Source: Annual Congress 2010 - Tuberculosis drug resistance
Year: 2010
Effectiveness of chemotherapy in newly detected patients with pulmonary tuberculosis with poly-resistance
Source: Annual Congress 2010 - Tuberculosis drug resistance
Year: 2010
Factors influencing time to sputum conversion in smear-positive pulmonary tuberculosis
Source: Annual Congress 2010 - Prognosis of tuberculosis
Year: 2010
A T-cell-based assay for rapid diagnosis of difficult cases of tuberculosis (TB): smear negative pulmonary and extra-pulmonary TB
Source: Eur Respir J 2005; 26: Suppl. 49, 240s
Year: 2005
Evaluation of relapse and defaulter pulmonary tuberculosis patients
Source: Eur Respir J 2005; 26: Suppl. 49, 647s
Year: 2005
Supervised and induced sputum among patients with smear-negative pulmonary tuberculosis
Source: Eur Respir J 2008; 31: 1085-1090
Year: 2008
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept